Cook Medical Launches First Drug-Eluting Stent in Australia to Treat Peripheral Arterial Disease (PAD)

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical, a world leader in minimally invasive medical technologies, has launched a first-of-its-kind drug-eluting peripheral stent in Australia, the Zilver® PTX® Drug-Eluting Peripheral Stent. The device, which is available in more than 50 countries, is registered with Australia’s Therapeutic Goods Administration (TGA) and is now available to physicians there as a new treatment option for patients with lesions in the SFA, the largest artery in the leg.